The Zhitong Finance App learned that according to the latest data from the Hong Kong Stock Exchange, on December 15, Guo Huaqing, a non-executive director, increased his holdings of Keji Pharmaceutical (02171.HK) by 30,000 shares, at a price of HK$1,498 per share, for a total amount of HK$449,400. The latest number of shares held after the increase was approximately 224 million shares, with a shareholding ratio of 38.75%.

The Zhitong Finance App learned that according to the latest data from the Hong Kong Stock Exchange, on December 15, Guo Huaqing, a non-executive director, increased his holdings of Keji Pharmaceutical (02171.HK) by 30,000 shares, at a price of HK$1,498 per share, for a total amount of HK$449,400. The latest number of shares held after the increase was approximately 224 million shares, with a shareholding ratio of 38.75%.